Latest Breaking News On - Bitterroot bio - Page 1 : comparemela.com

Bitterroot Bio Announces Dosing of First Participants in a Phase 1, First-in-Human Study of BRB-002 in Healthy Volunteers

Bitterroot Bio Announces Dosing of First Participants in a Phase 1, First-in-Human Study of BRB-002 in Healthy Volunteers
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Craig bassonBitterroot australia pty ltdBitterroot bio incNucleus networkBio announces dosingFirst participantsFirst in human studyAustralia pty ltdBitterroot bioChief medical officer

Bitterroot Bio and Biotheus Announce Research Collaboration

Collaboration aims to discover novel bispecific proteins targeting immune modulators and inflammatory pathways implicated in cardiovascular disease.

Jun baoPavan cheruvuXiaolin liuBitterroot bio

Bitterroot Bio and Biotheus Announce Research Collaboration to Develop Bispecific Proteins in Cardio-Immunology

Bitterroot Bio and Biotheus Announce Research Collaboration to Develop Bispecific Proteins in Cardio-Immunology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jun baoXiaolin liuPavan cheruvuBitterroot bio

BioSpace Names Most Promising New Biopharma Companies to Watch in 2024

BioSpace Names Most Promising New Biopharma Companies to Watch in 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJosh goodwinEntact bioNido biosciencesNextgen classRapport therapeuticsApogee therapeuticsAera therapeuticsGen bioOrbital therapeuticsAbdera therapeuticsBitterroot bioConvergent therapeuticsAscidian therapeuticsDelve bioAlterome therapeutics

Bitterroot Bio to Present Preclinical Research at American Heart Association Conference

PALO ALTO, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) Bitterroot Bio, a biotechnology company focused on developing novel immunotherapies in cardiovascular disease, has been selected to present research at the upcoming

United statesLori clerkinCraig bassonAmerican heart associationBitterroot bio incAmerican heart association scientific sessionsPennsylvania convention centerAttenuates atherosclerosisApoe mouse modelChief medical officerBitterroot bio